Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients

NCT02125734 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
COPD

Interventions

DRUG: QVA149
DRUG: Tiotropium

Sponsor

Novartis Pharmaceuticals